UK Edition
AdvertiseSubmit Company
Pharma JournalEvidence-Based Pharmaceutical Intelligence
CLINICAL RESEARCH

APCER Life Sciences

Pharmacovigilance and regulatory affairs services provider

APCER Life Sciences logo

APCER Life Sciences

Clinical ResearchGlobal (North America, UK, Europe, Asia)

Pharmacovigilance and regulatory affairs services provider

Visit WebsiteContact Company

About APCER Life Sciences

With a workforce comprising 100% healthcare professionals, including a 15% physician pool, APCER Life Sciences brings deep clinical and scientific expertise to every stage of the product lifecycle. The company is a specialist pharmacovigilance contract research organisation (CRO) serving pharmaceutical, biotech, and medical device partners across more than 100 markets worldwide.

Over nearly two decades, APCER has built an integrated service model that spans the full spectrum of drug safety and regulatory requirements. Core capabilities include ICSR case processing, literature surveillance, aggregate reporting, signal management, and risk management programmes such as REMS. The company also provides QPPV and PSMF support, medical information through an integrated response centre, regulatory affairs, medical writing, and quality assurance, enabling sponsors to consolidate multiple functions under a single, accountable partner.

Technology sits at the centre of the APCER model. The firm positions its solutions as fit-for-purpose technology-powered platforms, designed to meet the highest regulatory standards while offering clients scalable and flexible engagement models. This approach supports both small innovators and established organisations navigating complex global regulations.

The company operates across North America, the United Kingdom, Europe, and Asia, and counts more than 90 customers within its client base. Its stated focus is on building strategic partnerships grounded in trust, transparency, and a customer-first mindset, with the overarching goal of helping safe and effective therapies reach patients worldwide.

Further information is available at apcerls.com.

Areas of Expertise

Medical WritingPharmacovigilanceQuality AssuranceRegulatory Affairs

Services & Capabilities

Medical WritingPharmacovigilanceQuality AssuranceRegulatory Affairs
Similar Companies

More in Clinical Research

A

AXIS

Founded in 2004 and headquartered in Hyderabad, Telangana, Axis Clinicals Limited has grown into an internationally recognised contract research organisation operating across India, the United States, and Mexico. With a workforce of more than 500 professionals, the company serves pharmaceutical, biotechnology, and generic drug sponsors seeking a single partner for early- and late-phase development. The company's core strength lies in bioavailability and bioequivalence (BA/BE) studies, which account for approximately half of annual revenue and are conducted from dedicated facilities in Hyderabad and Ahmedabad. Alongside BA/BE work, Axis Clinicals delivers pharmacokinetic and pharmacodynamic (PK/PD) patient studies, Phase I through Phase IV clinical trials, bio-analytical laboratory services, and a clinical central laboratory. Supporting disciplines include project management, PK biostatistics and programming, medical writing, regulatory affairs, clinical data management, and quality assurance and compliance. Facilities carry DCGI and NABL accreditation under ISO 15189 and have been inspected and approved by the US FDA, UK MHRA, Brazil ANVISA, and France ANSM, confirming adherence to ICH GCP and GLP guidelines across international markets. A parallel US entity, Axis Clinicals USA, serves North American sponsors seeking early-phase trial unit capabilities. Further information is available at axisclinicals.com.

View profile
A

Accelsiors

With more than two decades of experience accelerating clinical development for emerging biotech companies, Accelsiors operates as a full-service global Contract Research Organisation (CRO) built specifically around the needs of smaller, agile biopharma developers. The company positions itself as a strategic partner rather than a transactional vendor, offering smart, tailored solutions across the full development continuum. Accelsiors delivers an extensive range of clinical trial services covering early-stage and late-stage development. Early-stage capabilities include project management, central and risk-based monitoring, regulatory monitoring and site management, data management, record management, safety management and pharmacovigilance, quality assurance, biostatistics, medical writing, and clinical pharmacology including modelling and simulation. Late-phase services extend to real-world evidence trials, with dedicated consultancy arms covering regulatory, medical and pharmacovigilance, legal and GDPR, and drug development consultancy. A functional service provider (FSP) model is also available for clients seeking embedded expertise rather than full outsourcing. The company serves a broad span of therapeutic areas, including oncology, autoimmune disorders, infectious diseases, endocrinology, respiratory, hepatology and gastrointestinal, nervous system, nephrology, women's health, nephrology, biosimilars, generics, paediatrics, cell and gene therapy, vaccines, orphan disorders, and microbiome research. This breadth reflects the company's positioning as a single-partner solution for biotech pipelines spanning multiple indications. Accelsiors has developed a suite of proprietary methodologies and platforms, among them Hexa-Helix, Quality Drive, StrongCORE Scientific, AcceleROUTE, WideSCOPE Intelligence, ProPATIENT Solutions, and AcceShield, each designed to support specific functions within the clinical development workflow. Further information is available at accelsiors.com.

View profile
4

4MCS

With a cumulative team experience of over 130 years in clinical trials and the pharmaceutical industry, 4MCS (4 Medical Clinical Solutions) operates as a patient-centred Site Management Organisation dedicated to improving the quality of research in healthcare. The organisation runs its own network of research sites and recruits volunteers from a patient population of over 10 million, giving sponsors direct access to well-characterised cohorts without the delays associated with conventional site activation. The therapeutic breadth across the site's active clinical trial programme spans respiratory conditions including asthma and COPD, cardiovascular disease areas such as atrial fibrillation and hypertension, metabolic and hepatic conditions including fatty liver disease, and a range of central nervous system and dermatological indications. Migraine, depression, general anxiety disorder, myasthenia gravis, lower back pain, psoriasis, and premenopausal effects on sexual health are among the specific areas where the organisation is actively recruiting or conducting clinical research. The patient-centred model that underpins the 4MCS approach prioritises participant experience alongside data quality, with a stated mission linked to improving patient quality of life through evidence generation. The organisation maintains dedicated disease and therapy area specialisms within its leadership and operations structure, supported by an established research site infrastructure across the United Kingdom. Further information is available at 4mcs.co.uk.

View profile
AdvertisementTeksyte LTD

List Your Company

Showcase your company to thousands of pharma professionals.

Submit Listing

Advertise With Us

Reach decision-makers in the pharmaceutical industry.

Learn More

We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy